A T cell receptor β chain–directed antibody fusion molecule activates and expands subsets of T cells to promote antitumor activity.

MLA

Hsu, Jonathan, et al. “A T Cell Receptor β Chain–directed Antibody Fusion Molecule Activates and Expands Subsets of T Cells to Promote Antitumor Activity.” Science Translational Medicine, vol. 15, no. 724, Nov. 2023, pp. 1–18. EBSCOhost, https://doi.org/10.1126/scitranslmed.adi0258.

APA

Hsu, J., Donahue, R. N., Katragadda, M., Lowry, J., Huang, W., Srinivasan, K., Guntas, G., Tang, J., Servattalab, R., Moisan, J., Tsai, Y.-T., Stoop, A., Palakurthi, S., Chopra, R., Liu, K., Wherry, E. J., Su, Z., Gulley, J. L., Bayliffe, A., & Schlom, J. (2023). A T cell receptor β chain–directed antibody fusion molecule activates and expands subsets of T cells to promote antitumor activity. Science Translational Medicine, 15(724), 1–18. https://doi.org/10.1126/scitranslmed.adi0258

Chicago

Hsu, Jonathan, Renee N. Donahue, Madan Katragadda, Jessica Lowry, Wei Huang, Karunya Srinivasan, Gurkan Guntas, et al. 2023. “A T Cell Receptor β Chain–directed Antibody Fusion Molecule Activates and Expands Subsets of T Cells to Promote Antitumor Activity.” Science Translational Medicine 15 (724): 1–18. doi:10.1126/scitranslmed.adi0258.